TD Cowen analyst maintained a Buy rating on GoodRx Holdings today and set a price target of $16.00. The company’s shares closed yesterday at $7.92.
GoodRx Holdings has an analyst consensus of Moderate Buy, with a price target consensus of $9.88, implying a 24.75% upside from current levels. (TipRanks)